The risk of dying of prostate cancer was four times higher among those with a higher (3.9 (95% confidence interval (CI)=1.1–14)) or lower (3.8 (95%CI=1.1–13)) MUC-1 expression than among those with an MUC-1 expression within the normal range. Here, MUC1 is linked to prostate carcinoma.